Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kraig Biocraft Laboratories ( (KBLB) ) has shared an update.
On January 21, 2025, Kraig Biocraft Laboratories entered into a Standby Equity Purchase Agreement with YA II PN, LTD., securing up to $10 million in capital to support the growth and commercialization of its spider silk production. The agreement offers flexibility in accessing capital over the next 36 months, allowing the company to expand production capacity, develop new consumer products, and establish sales partnerships, thereby strengthening its market position in eco-friendly and cost-effective spider silk production.
More about Kraig Biocraft Laboratories
Kraig Biocraft Laboratories, Inc. is a biotechnology company that leads in developing genetically engineered spider silk-based fiber technologies. The company has made significant scientific advances in spider silk technology, which could have major implications for the global textile industry.
YTD Price Performance: -4.17%
Average Trading Volume: 720,715
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $96.05M
For detailed information about KBLB stock, go to TipRanks’ Stock Analysis page.